Alzheimer’s is one of the most devastating diseases of our time. By 2050, more than 150 million people are expected to live with dementia. Yet today, there are still no cures.
Aerska is developing RNA interference (RNAi) therapies designed to silence the genes that drive brain diseases, before symptoms appear.
Alzheimer’s is one of the most devastating diseases of our time. By 2050, more than 150 million people are expected to live with dementia. Yet today, there are still no cures.
Aerska is developing RNA interference (RNAi) therapies designed to silence the genes that drive brain diseases, before symptoms appear.
Explore companies within the same category